Technologies Available for Licensing
| Life Sciences | Engineering | ||
Antibodies
- R-7030: Monoclonal Antibody Against Human MMP9
- R-7137: Mouse Monoclonal Antibody against Estrogen Receptor
- R-7138: Monoclonal Antibody against Intact Estrogen Receptor
- R-7224: Monoclonal Antibody Against Oxidative DNA Lesion 8-Oxoguanine
- R-7235: Monoclonal Antibody Against PETA3-CD151
- R-7326: Polyclonal Antibody Against NG2
- R-7419: Anti Sprouty Antibody
- R-7431: Monoclonal Antibody Against Kunitz Proteinase Inhibitor Domain of APP
- R-7503: Monoclonal Antibody Against NG2 Clone 69
- R-7551: Monoclonal Antibody Against Amyloid Beta
- R-7632: Monoclonal Antibody Against NG2 Clone 147
- R-7643: CoREST Antibody
- R-7753: Monoclonal Antibody Against LcrV
- R-7795: Antibodies Against BRK protein
- R-7850: Monoclonal Antibody Against PAR-3
- R-7972: Monoclonal Antibody to MAZ
- R-7981: Monoclonal Antibody to NSC6 and NSC32
- R-7982: Monoclonal Antibody to NSC6 and NSC32
- R-8093: Monoclonal Antibody Against Ft LVS SucB Clone 195
- R-8094: Monoclonal Antibody Against LVS LPS 10
- R-8095: Monoclonal Antibody Against Ft LVS DnaK Clone 193
- R-8096: Monoclonal Antibody Against Ft LVS basterioferritin Clone 163
- R-8097: Monoclonal Antibody Against Ft LVS SucC clone 121
- R-8098: Monoclonal Antibody Against Ft LVS LopA-Tu16 Clone 164
- R-8099: Monoclonal Antibody Against Ft LVS FopA clone 26
- R-8100: Monoclonal Antibody against Ft LVS LPS Clone 12
- R-8101: Monoclonal Antibody Against Ft LVS Rp1L 109
- R-8102: Monoclonal Antibody Against Anti Ft LVS SucB Clone 158
- R-8103: Monoclonal Antibody Against Anti Ft LVS LpnATu14 Clone 14
- R-8104: Monoclonal Antibody Against Anti Ft LVS LpnATu14 Clone 80
- R-8105: Monoclonal Antibody Against Anti Ft LVS LpnATu14 Clone 105
- R-8106: Monoclonal Antibody Against Anti Ft LVS LpnATu14 Clone 146
- R-8107: Monoclonal Antibody to Anti Ft LVS FopA clone 47
- R-8138: Monoclonal Antibody to Vaccina Virus protein F17R (VP11)
- R-8200: Monoclonal Antibodies to the Abeta binding domain of MBP
- R-8277: Mouse Monoclonal Antibody Against 8-oxoguanine DNA Glycosylase
Diagnostics
- R-7450: SCAN-1
- R-7896: Accurate Determination of Respiratory Rate in Real Time from Pulse Oximetry Data
- R-7974: Optical Coherance Tomography System for Cancer Diagnosis
- R-8054: New Efficient Carbon Nanotubes for Biomedical Applications-1
- R-8057: Novel Targets for treating and diagnosing Lyme disease
- R-8141: MicroRNAs as Therapeutic Targets in Cancer
- R-8152: Diagnosis of Cliopathies
- R-8158: MicroRNA screen for Colorectal cancer diagnosis-1
- R-8165: A Sensitive and Specifc Molecular Diagnostic for Essential Thrombocythemia
- R-8184: MicroRNA Screen for Predicting and Treating Cancers
- R-8218: Novel EGFR Truncations as Biomarkers and Drug Targets
- R-8288: Novel magnetic graphene-based nanomaterials for multimodal imaging
- R-8348: Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
- R-8411: High Throughput screening and selection of live cells
Drug Delivery
- R-7220: Membrane Pore Inhibiting Agents for Treating Infections
- R-7440: Methods of Producing Gene Therapy Vectors
- R-7520: Reliable High Capacity Gene Therapy Vectors
- R-7694: Drug Conjugates for More Potent Cancer Treatment-1
- R-7998: Hydrogel Replacement Disc Therapy
- R-8124: A Platform Technology for the Simple Modification of Viral Surfaces
- R-8272: Enhancing therapeutic index by Programmed Introduction of Multiple Refractory Periods to Cells
- R-8281: Optical Control of Cardiac Function
- R-8286: A Novel Computational Designed AAV Rep Gene for the Efficient Generation of rAAV
Medical Devices
- R-7450: SCAN-1
- R-7974: Optical Coherance Tomography System for Cancer Diagnosis
- R-8116: Biomechanical Treatment for Degenerative Bone diseases
- R-8209: Method for continuous sample concentration and buffer change in droplet microfluidics
- R-8272: Enhancing therapeutic index by Programmed Introduction of Multiple Refractory Periods to Cells
- R-8348: Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
Research Tools and Reagents
- R-7520: Reliable High Capacity Gene Therapy Vectors
- R-7541: Transgenic Triple Mutant Mouse for Alzheimer's Research
- R-7651: A Yeast Model for Screening Mutations in Cystinosis
- R-7676: Mustang, a Novel Therapeutic Target for Fracture Repair
- R-7697: Inducible Transgenic Mouse Model for Heart Failure
- R-7881: New Method for Polymer Design and Development
- R-8021: Fluorescent Analogs for the Investigation of Amyloid Formation
- R-8029: Novel Purple Fluorescent biomarket for yeast
- R-8040: One Step Design for Polymers with Alternating Backbone Constituents
- R-8054: New Efficient Carbon Nanotubes for Biomedical Applications-1
- R-8132: A glycation collagen matrix for investigating glycated tissue and diabetic wound healing (2)
- R-8166: Stable Packaging Cell Lines
- R-8203: Inducible Transgenic Mouse Model for Skin Disorders-1
- R-8253: An inducible cell line for cancer research modulating Akt and c-Myc
- R-8286: A Novel Computational Designed AAV Rep Gene
- R-8288: Novel magnetic graphene-based nanomaterials for multimodal imaging
- R-8318: cellular Preparation for Wound Managment
- R-8411: High Throughput screening and selection of live cells
Therapeutics
- R-7220: Membrane Pore Inhibiting Agents for Treating Infections
- R-7235: Monoclonal Antibody against CD151 PETA3
- R-7440: Methods of Producing Gene Therapy Vectors
- R-7520: Reliable High Capacity Gene Therapy Vectors
- R-7676: Mustang, a Novel Therapeutic Target for Fracture Repair
- R-7687: New Collegenase formulation for the Treatment of Wounds
- R-7693: Second Generation Fatty Acid Taxoid conjugates for Treatment of Cancer-1
- R-7694: Drug Conjugates for More Potent Cancer Treatment-1
- R-7759: Slow Onset Inhibitors for Use as Novel Antibiotics-1
- R-7778: Small Peptide Inhibitors for treating Chronic Inflammation-1
- R-7932: Novel Nucleotide Excision Repair Inhibitors for Increasing Chemosensitivity
- R-7987: Novel Diagnostic and Therapeutic Target for Breast Cancer and other Carcinomas
- R-7998: Hydrogel Replacement Disc Therapy
- R-8036: Attenuated Viruses useful for Vaccines
- R-8040: One Step Design for Polymers with Alternating Backbone Constituents
- R-8042: Novel Peptides for the Treatment of Amyloidoses
- R-8048: Novel Oncolytic Treatment for Neuroblastoma
- R-8057: Novel Targets for treating and diagnosing Lyme disease
- R-8111: Novel drug targets for endocannabinoids-1
- R-8114: Novel Compositions and Methods for the Treatment of Angioedemia and Vascular Leakage
- R-8116: Biomechanical Treatment for Degenerative Bone diseases
- R-8124: A Platform Technology for the Simple Modification of Viral Surfaces
- R-8134: Novel Compounds for MMP and Inflammatory Cytokine Inhibitors-1
- R-8141: MicroRNAs as Therapeutic Targets in Cancer
- R-8148: Short Peptide Inhibitors of MT1MMP
- R-8151: Intravenous Curcumin to Prevent Injury Progression
- R-8152: Diagnosis of Cliopathies
- R-8166: Stable Packaging Cell Lines
- R-8179: Novel Thiolactomycin Analogues as Anti-infectives
- R-8195: Novel treatment to Enhance Healing of Chronic wounds
- R-8218: Novel EGFR Truncations as Biomarkers and Drug Targets
- R-8232: Novel and Specific Inhibitors of MMP9
- R-8266: Novel Peptide Therapeutic for the Treatment of Osteoporosis and Related Fractures
- R-8272: Enhancing therapeutic index by Programmed Introduction of Multiple Refractory Periods to Cells
- R-8275: Inhibition of the soluble extracellular domain of E-cadherin as a novel anti-cancer drug
- R-8281: Optical Control of Cardiac Function
- R-8286: A Novel Computational Designed AAV Rep Gene for the Efficient Generation of rAAV
- R-8311: Small Molecule Anti Cancer Compounds that Selectively Target MMP9
- R-8333: Novel soluble peptides for the treatment of diabetes and obesity
- R-8348: Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
- R-8349: Unique and specific target for screening molecules suitable for the development of non-hormonal male contraceptives
Computer Technology
Electronics and Electronic Materials
- R-7822: Photonic Waveguide Device for Modal Control
- R-7977: Silylation Carbon Nanotubes and Methods of Making Same
- R-7986: Lithium Ion Battery Electrode and Method for Manufacture of the Same
- R-8053: Large Area PIN Diode with Reduced Capacitance
- R-8085: High Quality Substrates for Boron Arsenide Semiconductor Devices
Medical Imaging and Diagnostics
- R-7151: 3-D Virtual Colonoscopy Portfolio
- R-7413: Accurate Computing of Tissue Percentages Inside Medical Images
- R-7414: Quantitative Analysis on Carotid Stenosis for Mass Screening of Stroke
- R-7617: Computer Assisted Detection of Lesions in Volumetric Medical Images
- R-7902: Detection of Stem Cells from Magnetic Resonance Spectroscopy Measurements
- R-7997: Apparatus and Method of Detection and Localized Treatment of Abnormal Conditions
- R-8121: Accurate Computing of Tissue Percentages Inside Each Medical Image Voxel
- R-8155: Selection of Optimal Views for CT Reconstruction
Nanotechnology
- R-7416: Breakthrough Nanofibrous Membranes for Water Purification
- R-7533: Flame Retardant and UV Absorptive Polymethylmethacrylate (PMMA) Nanocomposites
- R-7721: Large-scale Synthesis of Perovskite Nanostructures
- R-7794: Method for the Synthesis of Single Crystalline ABO4 Type Nanorods
- R-7968: Iron Oxide Nanostructures
- R-7977: Silylation Carbon Nanotubes and Methods of Making Same
- R-7978: Methods for Controlling Silica Deposition onto Carbon Nanotube Surfaces
- R-8076: Manufacture of Platinum Nanoparticles for the Treatment of Cancer and Methods of Use
- R-8080: Methods of Controlling the Morphology of Perovskite Submicron-Sized Particles during Molten Salt Synthesis
Screens and Assays
- R-7220: Membrane Pore Inhibiting Agents for Treating Infections
- R-7651: A Yeast Model for Screening Mutations in Cystinosis
- R-8021: Fluorescent Analogs for the Investigation of Amyloid Formation
- R-8029: Novel Purple Fluorescent biomarket for yeast
- R-8036: Attenuated Viruses useful for Vaccines
- R-8111: Novel drug targets for endocannabinoids-1
- R-8132: A glycation collagen matrix for investigating glycated tissue and diabetic wound healing (2)
- R-8141: MicroRNAs as Therapeutic Targets in Cancer
- R-8158: MicroRNA screen for Colorectal cancer diagnosis-1
- R-8184: MicroRNA Screen for Predicting and Treating Cancers
- R-8209: Method for continuous sample concentration and buffer change in droplet microfluidics
- R-8253: An inducible cell line for cancer research modulating Akt and c-Myc
- R-8281: Optical Control of Cardiac Function
- R-8318: cellular Preparation for Wound Managment
- R-8348: Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
- R-8349: Unique and specific target for screening molecules suitable for the development of non-hormonal male contraceptives
- R-8411: High Throughput screening and selection of live cells
